HCV NS5B

Hepatitis C Virus NS5B Recombinant
Shipped with Ice Packs
In Stock

Description

Mechanistic Role in HCV Replication

NS5B performs de novo initiation and elongation:

  • Initiation: Requires GTP-dependent priming. High NTP concentrations (100–400 μM) are needed for efficient RNA synthesis .

  • Elongation: Primer extension occurs with lower NTP requirements (0.03–0.09 μM) .

The enzyme exhibits genotype-specific activity: HCV-1b NS5B is 5–10 times more active than HCV-1a variants .

Inhibitor Classes

NS5B inhibitors are divided into nucleotide/nucleoside analogs (NIs) and non-nucleoside inhibitors (NNIs):

Inhibitor ClassMechanismExamplesStatus
Nucleotide AnaloguesIncorporation into RNA, chain terminationSofosbuvir (SOF)Approved (FDA, 2013)
Non-Nucleoside InhibitorsAllosteric binding to thumb/palm sitesDasabuvir (DAS), Radalbuvir (RDV)Approved (DAS) / Clinical trials (RDV)

Key Approved Regimens:

  • SOF + Ledipasvir (LDV): Targets NS5B (SOF) and NS5A (LDV) .

  • Viekira Pak: Combines DAS (NS5B) with ombitasvir, paritaprevir, and ritonavir .

Genetic Variability and Resistance

HCV NS5B harbors natural polymorphisms and treatment-induced mutations:

SubstitutionImpact on TherapyGenotype PrevalenceReference
S282T (NI resistance)High-level resistance to SOFLow in genotype 1a/b
C316N (NNI resistance)Linked to virologic failure in SOF/LDV therapy55% in genotype 1b
A218S/Q464EAssociated with treatment failure in salvage casesGenotype 1b

Product Specs

Introduction
HCV, a member of the Flaviviridae family, is a small (50nm), enveloped, single-stranded RNA virus with a positive sense orientation. It exhibits a high replication rate, generating approximately one trillion particles per day in an infected individual. The absence of proofreading mechanisms in the HCV RNA polymerase contributes to its exceptionally high mutation rate, potentially enabling it to evade the host's immune system. HCV is categorized into six genotypes (1-6), each with multiple subtypes. The prevalence and distribution of these genotypes vary globally. Genotype plays a crucial role in determining the potential response to interferon-based therapy and its duration. Notably, genotypes 1 and 4 demonstrate reduced responsiveness to interferon-based treatment compared to genotypes 2, 3, 5, and 6.
Description
This recombinant protein, derived from E. coli, encompasses the full length of the NS5B immunodominant regions of HCV genotype 1B. It is fused to a 6xHis tag at its C-terminus.
Purity
SDS-PAGE analysis indicates a protein purity greater than 95%.
Formulation
The protein is supplied in a buffer containing 1.5M urea, 25mM Tris-HCl (pH 8.0), 0.2% Triton-X, and 50% glycerol.
Stability
For optimal stability, HCV NS5B should be stored below -18°C. While it remains stable at 4°C for up to one week, repeated freeze-thaw cycles should be avoided.
Applications
HCV NS5B serves as an excellent antigen in ELISA and Western blotting applications for detecting HCV, exhibiting minimal specificity issues.
Purification Method
HCV NS5B Genotype-1b protein was purified by proprietary chromatographic technique.
Specificity
Immunoreactive with sera of HCV-infected individuals.

Q&A

What is the basic structure and function of HCV NS5B?

HCV NS5B is a 65 kDa protein that carries the RNA-dependent RNA polymerase enzymatic activity essential for HCV replication . Structurally, NS5B resembles a right hand with three subdomains called fingers, palm, and thumb . The palm subdomain contains three well-preserved motifs (A, B, and C) that form the catalytic center . The last 21 residues at the C-terminus serve as a hydrophobic anchor to the endoplasmic reticulum membrane, which is crucial for proper localization of the protein in the viral replication complex .

What are the critical catalytic motifs in NS5B?

NS5B contains three essential conserved motifs in its palm subdomain:

  • Motif A (D220-X(4)-D225): D220 is involved in coordinating divalent cations (Mg²⁺ and/or Mn²⁺) essential for phosphodiester bond formation

  • Motif B (S282-X(8)-N291): Involved in selecting ribonucleoside triphosphates over dNTPs, thus determining RNA synthesis specificity

  • Motif C (G317D318D319): D318 and D319 coordinate divalent cations necessary for catalytic activity

These motifs together form the active site where nucleotide addition occurs during RNA synthesis.

How does NS5B initiate viral RNA synthesis?

NS5B initiates RNA polymerization de novo (without requiring a primer) and first copies the viral (+)RNA genome to generate (-)RNA molecules . In a second step, the 3'-end of the (-)RNA serves as an initiation site for the polymerase to catalyze the synthesis of progeny (+)RNAs . Real-time 1H NMR analysis has shown that when using partially double-stranded RNA templates, NS5B-catalyzed RNA synthesis exhibits a pronounced lag phase before processive polymerization begins, suggesting that secondary structure in the template can impede polymerase activity .

Which viral and host proteins interact with NS5B?

NS5B functions within a membrane-associated multiprotein complex and interacts with several viral and host proteins:

  • Viral proteins: NS5A (particularly domains 2 and 3)

  • Host factors: Cyclophilin A (CypA), Cyclophilin B (CypB), retinoblastoma tumor suppressor, and the cellular kinase Akt

These interactions are critical for the formation and function of the viral replication complex. Some interactions, such as with the retinoblastoma tumor suppressor, require partial denaturation of NS5B and subsequent loss of polymerase activity .

How does NS5B interact with NS5A, and why is this interaction important?

NMR spectroscopy has revealed that NS5B interacts with the unfolded domains 2 and 3 of NS5A (NS5A-D2 and NS5A-D3) . Interestingly, both HCV NS5B and host CypA share a common binding site on NS5A-D2 . This shared binding site may function as a regulatory mechanism for HCV replication, potentially controlling the association of these proteins in the replication complex . This interaction is significant because both NS5A and NS5B are essential components of the HCV replication machinery.

What is the significance of Cyclophilin A interactions with NS5B?

CypA has been identified as a major player in both HCV replication and sensitivity to cyclophilin inhibitors like Cyclosporin A (CsA) . While earlier studies proposed Cyclophilin B as the target of CsA and a positive regulator of NS5B, recent evidence points to CypA as the key factor . Mutations located in the second half of NS5A confer the highest level of resistance to cyclophilin inhibitors, suggesting complex interactions between these proteins . The molecular mechanisms by which cyclophilin inhibitors exhibit anti-HCV activity remain incompletely understood, but involve interactions with NS5B, NS5A, and NS2 .

How does Akt phosphorylation affect NS5B function?

The cellular kinase Akt phosphorylates NS5B at multiple residues, including T53 and S282 . This phosphorylation generally leads to inactivation of the viral polymerase . Experimental studies using phosphomimetic mutations (substituting phosphorylatable residues with glutamic acid to mimic phosphorylation) have shown that such modifications result in NS5B proteins with significantly reduced RDRP activities . This suggests that phosphorylation by cellular kinases may serve as a host defense mechanism to inactivate the viral polymerase.

Which specific NS5B phosphorylation sites are critical for viral replication?

Research has identified several phosphorylation sites in NS5B that affect viral replication:

ResidueMutationEffect on Viral Replication
T53T53E (phosphomimetic)No viable virus recovered
T53T53A (phospho-deficient)Reduced viral titer at 15 days post-transfection
S282S282E (phosphomimetic)No viable virus recovered
S282S282A (phospho-deficient)No viable virus recovered

Notably, S282 is part of motif B, which is involved in nucleotide selection, explaining why modifications at this position severely impact viral replication .

What are the common NS5B mutations associated with drug resistance?

Several naturally occurring mutations in NS5B can reduce susceptibility to direct-acting antivirals:

MutationPrevalence in GenotypesResistance Association
Q309RCommon in all genotypes except 1bPosition under positive selection in genotype 5a
A333EDetected only in genotype 5aNot specified
C316NFound in 3 of 4 genotype 1b sequencesAssociated with resistance to HCV-796
D244N, S282T, C316Y, S326G, T329INot detected in analyzed sequencesPreviously described resistance mutations

These findings suggest that drug resistance testing may be valuable prior to initiating antiviral therapy for HCV .

How does the S282T mutation affect NS5B function and drug susceptibility?

The S282T mutation in NS5B's motif B is particularly significant as it can confer resistance to nucleoside inhibitors while affecting the enzyme's function. Since S282 is involved in distinguishing between ribonucleotides and deoxyribonucleotides, mutations at this position may alter substrate specificity . Interestingly, this mutation was not detected in a study of treatment-naïve South African patients, suggesting it may not be common as a naturally occurring polymorphism .

What methods are effective for studying NS5B-RNA interactions?

NMR spectroscopy has proven valuable for studying NS5B-RNA interactions at the molecular level. Using real-time 1D ¹H NMR spectroscopy, researchers have:

  • Monitored the folding/unfolding of RNA templates

  • Identified different binding modes between NS5B and structured versus unstructured RNA templates

  • Followed the kinetics of NS5B-catalyzed RNA synthesis in real-time

  • Detected the lag phase that precedes processive polymerization when using structured RNA templates

These NMR approaches provide insights into both the thermodynamics and kinetics of binary and ternary complex formation associated with conformational changes of the polymerase .

How can researchers assess NS5B phosphorylation experimentally?

To study NS5B phosphorylation:

  • In vitro phosphorylation assays: Using recombinant NS5B (potentially fused to a reporter like EGFP) and γ[³²P]-ATP as substrates

  • Gel electrophoresis: Resolving phosphorylated products by SDS-PAGE to detect radiolabeled proteins

  • Proteomic analysis: Extracting the NS5B band, performing trypsin digestion, and analyzing by mass spectrometry (providing up to 70% sequence coverage)

  • Mutagenesis studies: Creating phosphomimetic (S/T→E) or phospho-deficient (S/T→A) mutations to assess the functional consequences of phosphorylation

These approaches allow for identification of specific phosphorylation sites and evaluation of their impact on polymerase activity and viral replication.

What cell culture systems are suitable for studying NS5B function in the context of complete viral replication?

Researchers can use Huh-7.5 permissive cells transfected with in vitro transcribed RNAs derived from HCV complete infectious clones . This system allows for assessment of viral replication by measuring supernatant viral titers at different time points post-transfection (e.g., 6 and 15 days) . Such cell culture systems are valuable for evaluating how mutations in NS5B affect the complete viral life cycle, providing insights beyond what can be learned from in vitro biochemical assays with purified proteins.

How do RNA template structures influence NS5B activity?

NS5B exhibits different binding modes with structured versus unstructured RNA templates . NMR studies have revealed that the base pair at the edge of a stem structure in RNA represents the most stable component and serves as an energy barrier for polymerase activity . When NS5B operates on partially double-stranded RNA templates, its activity is substantially delayed, suggesting that the polymerase lacks RNA helicase activity . This observation emphasizes the need for additional RNA-modulating factors that likely assist NS5B during viral replication in infected cells.

What is the significance of inactive NS5B generated through phosphorylation?

The observation that Akt phosphorylation produces inactive NS5B raises important questions about the biological significance of this process . Two hypotheses merit further investigation:

  • Whether this inactivation represents a host defense mechanism resulting from interaction with cellular kinases

  • Whether the inactive NS5B serves alternative functions beyond RNA synthesis

These questions highlight the complex interplay between viral proteins and host cellular processes, pointing to areas requiring further experimental work .

Product Science Overview

Introduction

Hepatitis C Virus (HCV) is a significant global health concern, affecting millions of people worldwide. It is a positive-sense single-stranded RNA virus that primarily targets the liver, leading to chronic liver diseases such as cirrhosis and hepatocellular carcinoma. The HCV genome encodes a single polyprotein, which is processed into structural and nonstructural proteins. Among these, the nonstructural protein 5B (NS5B) is an RNA-dependent RNA polymerase crucial for viral replication.

Structure and Function of NS5B

NS5B is responsible for replicating the viral RNA by using the positive RNA strand as a template to catalyze the polymerization of ribonucleoside triphosphates (rNTP) during RNA replication . This unique function makes NS5B an attractive target for antiviral drug development. Several crystal structures of NS5B polymerase have been determined, providing insights into its mechanism of action and aiding in the design of inhibitors .

Recombinant NS5B

Recombinant NS5B refers to the NS5B protein expressed in a heterologous system, such as bacteria or yeast, for research and therapeutic purposes. The recombinant form allows for detailed biochemical and structural studies, which are essential for understanding the enzyme’s function and developing specific inhibitors . The expression and initial biochemical characterization of recombinant NS5B polymerase have been described, highlighting its potential as a therapeutic target .

Importance in HCV Research

NS5B is a critical component in the life cycle of HCV, and its inhibition can effectively halt viral replication. The development of direct-acting antivirals (DAAs) targeting NS5B has revolutionized HCV treatment, offering high cure rates with fewer side effects compared to previous therapies . The study of recombinant NS5B has been instrumental in identifying and optimizing these inhibitors, making it a cornerstone of HCV research.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.